Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

A Hackathon Demonstrates the Need for Deep Learning in R&D

Posted on January 12th, 2018 by in Pharma R&D

Today’s life science companies find themselves dealing with an interesting dilemma. With the help of many technological breakthroughs, they now have access to tons of data bursting with potential. Continue reading “A Hackathon Demonstrates the Need for Deep Learning in R&D” »

Unifying Data Standards to Promote Innovation

Posted on January 5th, 2018 by in Pharma R&D

blur-1853262_1280

Imagine that you are spending your days as a researcher in the life sciences, trying to use your skills, expertise and determination to do innovative, potentially life-saving work, but then you keep getting bogged down by the “busy work” of having to clean up data. Continue reading “Unifying Data Standards to Promote Innovation” »

Extreme Makeover: Clinical Trials Edition

Posted on December 4th, 2017 by in Pharma R&D

In a piece featured in the PharmaTimes, Katrina Megget points out the sad state of affairs when it comes to clinical trials, highlighting some appalling stats on the frequent failure to reach enrollment targets (in some cases, not finding any patients at all) and the tendency for studies to go on far longer than anticipated. Continue reading “Extreme Makeover: Clinical Trials Edition” »

As Drug Development Costs Skyrocket, AI Offers Some Hope

Posted on November 20th, 2017 by in Pharma R&D

Last year, researchers from the Tufts Center for the Study of Drug Development published a paper in the Journal of Health Economics that provided an assessment of the current cost for pharmaceutical companies to discover and develop new drugs and biologics. Continue reading “As Drug Development Costs Skyrocket, AI Offers Some Hope” »

  1. 1
  2. 2
  3. 3